Frankie A. Holmes

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Kathy D. Miller, Linnea Chap, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2005 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +17

THE IMPACT OF NATIONAL CANCER ACT

Frankie A. Holmes, Ronald S. Walters, Richard L. Theriault et al. · JNCI Journal of the National Cancer Institute · 1991 · 803 citations

Medicine, Oncology, Pharmacology +10

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

Frankie A. Holmes, R S Walters, R. Theriault et al. · JNCI Journal of the National Cancer Institute · 1991 · 745 citations

Medicine, Oncology, Pharmacology +12

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

Stephen E. Jones, Frankie A. Holmes, Joyce O’Shaughnessy et al. · Journal of Clinical Oncology · 2009 · 586 citations

Medicine, Oncology, Pharmacology +11